NovoCure Ownership | Who Owns NovoCure?


OverviewForecastRevenueFinancialsChartTranscripts

NovoCure Ownership Summary


NovoCure is owned by 52.67% institutional investors, 9.81% insiders, and 37.52% retail investors. Fmr is the largest institutional shareholder, holding 15.03% of NVCR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 7.08% of its assets in NovoCure shares.

NVCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNovoCure52.67%9.81%37.52%
SectorHealthcare Stocks 232.51%10.72%-143.23%
IndustryMedical Instruments & Supplies Stocks31.73%13.63%54.64%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.77M15.03%$216.67M
Blackrock funding, inc. /de13.54M12.10%$175.09M
Blackrock12.13M11.31%$207.83M
Vanguard group10.96M9.79%$141.69M
Soleus capital management8.53M7.62%$110.30M
Morgan stanley5.07M4.53%$65.55M
State street2.58M2.30%$33.32B
Geode capital management2.48M2.21%$32.03M
Balyasny asset management2.27M2.03%$40.41M
Quantinno capital management lp1.52M1.36%$19.67M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Invus financial advisors350.88K6.74%$6.01M
Soleus capital management8.53M4.07%$110.30M
Palo alto investors lp1.26M3.00%$16.23M
Sio capital management413.83K1.35%$5.35M
Birchview capital, lp102.10K1.00%$1.32M
Bryce point capital48.98K0.77%$632.76K
Corton capital13.62K0.43%$175.93K
Washington capital management31.00K0.33%$400.83K
Vestal point capital, lp400.00K0.23%$5.17M
C worldwide group971.78K0.22%$12.56M

Top Buyers

HolderShares% AssetsChange
Morgan stanley5.07M0.00%4.15M
Blackrock12.13M0.00%3.05M
Balyasny asset management2.27M0.06%634.92K
Algert global682.86K0.15%538.24K
Vanguard group10.96M0.00%502.37K

Top Sellers

HolderShares% AssetsChange
Capital investors---8.95M
Capital world investors---2.00M
Soleus capital management8.53M4.07%-1.11M
Marshall wace, llp---1.03M
Ubs asset management americas226.50K0.00%-969.12K

New Positions

HolderShares% AssetsChangeValue
Schroder investment management group444.75K0.00%444.75K$5.75B
Sio capital management413.83K1.35%413.83K$5.35M
Vestal point capital, lp400.00K0.23%400.00K$5.17M
Axa investment managers371.77K0.01%371.77K$4.80M
Caprock group111.55K0.03%111.55K$1.44M

Sold Out

HolderChange
Northwestern mutual wealth management-1.00
Total investment management-1.00
Tfc financial management-3.00
Salem investment counselors-4.00
Pfg private wealth management-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025158-39.23%58,941,636-35.77%520.78%88-35.77%41-46.75%
Sep 30, 20252471.65%91,470,755-0.38%811.21%1313.15%748.82%
Jun 30, 20252474.22%94,464,090-0.79%841.14%12916.22%71-8.97%
Mar 31, 2025236-10.94%95,173,4933.94%861.21%110-14.06%782.63%
Dec 31, 20242495.51%88,494,339-4.72%811.11%11727.17%74-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S7.91M7.08%33.69K
Fidelity Growth Compy Commingled Pl O7.46M6.89%-
Fidelity Growth Company Fund5.44M4.86%-16.44K
American Funds SMALLCAP World A4.75M4.26%-3.59M
Vanguard US Total Market Shares ETF3.42M3.11%3.00K
Vanguard Total Stock Mkt Idx Inv3.37M3.01%-72.53K
American Funds Growth Fund of Amer A3.30M3.00%-5.51K
Capital Group Growth Fnd of Amer Comp3.30M2.96%-5.51K
Vanguard Small Cap Index2.57M2.30%-17.28K
iShares Russell 2000 ETF2.45M2.19%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 05, 2025Cordova Ashley Chief Executive OfficerBuy$996.86K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$116.30K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$58.00K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$57.50K
Jun 03, 2025Stafford Kristin-Sell$17.26K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q34-
2025 Q2-12
2025 Q1-20

NVCR Ownership FAQ


Who Owns NovoCure?

NovoCure shareholders are primarily institutional investors at 52.67%, followed by 9.81% insiders and 37.52% retail investors. The average institutional ownership in NovoCure's industry, Medical Instruments & Supplies Stocks, is 31.73%, which NovoCure exceeds.

Who owns the most shares of NovoCure?

NovoCure’s largest shareholders are Fmr (16.77M shares, 15.03%), Blackrock funding, inc. /de (13.54M shares, 12.10%), and Blackrock (12.13M shares, 11.31%). Together, they hold 38.44% of NovoCure’s total shares outstanding.

Does Blackrock own NovoCure?

Yes, BlackRock owns 11.31% of NovoCure, totaling 12.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 207.83M$. In the last quarter, BlackRock increased its holdings by 3.05M shares, a 33.55% change.

Who is NovoCure’s biggest shareholder by percentage of total assets invested?

Invus financial advisors is NovoCure’s biggest shareholder by percentage of total assets invested, with 6.74% of its assets in 350.88K NovoCure shares, valued at 6.01M$.

Who is the top mutual fund holder of NovoCure shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of NovoCure shares, with 7.08% of its total shares outstanding invested in 7.91M NovoCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools